You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 22, 2024

CLINICAL TRIALS PROFILE FOR CAYSTON


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Cayston

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01746095 ↗ Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients Completed Cystic Fibrosis Foundation Phase 2 2013-03-01 The purpose of this study is to determine whether AeroVanc treatment is safe and effective in reducing the number of MRSA colony forming units in the lungs of cystic fibrosis patients.
NCT01746095 ↗ Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients Completed Cystic Fibrosis Foundation Therapeutics Phase 2 2013-03-01 The purpose of this study is to determine whether AeroVanc treatment is safe and effective in reducing the number of MRSA colony forming units in the lungs of cystic fibrosis patients.
NCT01746095 ↗ Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients Completed Synteract, Inc. Phase 2 2013-03-01 The purpose of this study is to determine whether AeroVanc treatment is safe and effective in reducing the number of MRSA colony forming units in the lungs of cystic fibrosis patients.
NCT01746095 ↗ Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients Completed Savara Inc. Phase 2 2013-03-01 The purpose of this study is to determine whether AeroVanc treatment is safe and effective in reducing the number of MRSA colony forming units in the lungs of cystic fibrosis patients.
NCT02449031 ↗ Observational Study in Cystic Fibrosis Patients Using TOBI® Podhaler™ or Other FDA Approved Inhaled Antipseudomonal Antibacterial Drugs Active, not recruiting Cystic Fibrosis Foundation 2015-05-05 This is a multicenter, prospective, two cohort, observational study over a 5-year period in Cystic Fibrosis (CF) patients with chronic Pseudomonas aeruginosa infection.The study will collect data over 1 year on respiratory function, antibacterial effectiveness, and clinical outcomes of treatment with inhaled antipseudomonal antibiotics and data over 5 years on microbiological and safety assessments.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Cayston

Condition Name

Condition Name for Cayston
Intervention Trials
Cystic Fibrosis 3
Infection 1
Pseudomonas 1
Pseudomonas Aeruginosa in Cystic Fibrosis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Cayston
Intervention Trials
Cystic Fibrosis 4
Fibrosis 4
Pseudomonas Infections 3
Bronchiectasis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Cayston

Trials by Country

Trials by Country for Cayston
Location Trials
United States 56
United Kingdom 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Cayston
Location Trials
California 3
North Carolina 2
Virginia 2
Illinois 2
Massachusetts 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Cayston

Clinical Trial Phase

Clinical Trial Phase for Cayston
Clinical Trial Phase Trials
Phase 4 2
Phase 2 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Cayston
Clinical Trial Phase Trials
Active, not recruiting 2
Completed 2
Terminated 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Cayston

Sponsor Name

Sponsor Name for Cayston
Sponsor Trials
Gilead Sciences 2
Cystic Fibrosis Foundation 2
Cystic Fibrosis Foundation Therapeutics 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Cayston
Sponsor Trials
Other 11
Industry 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.